EKF Diagnostics (LON:EKF) Shares Cross Below 200 Day Moving Average – Time to Sell?

Shares of EKF Diagnostics Holdings plc (LON:EKF) crossed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 27.74 ($0.34) and traded as low as GBX 27.10 ($0.33). EKF Diagnostics shares last traded at GBX 28.40 ($0.35), with a volume of 169,312 shares changing hands.

EKF Diagnostics Stock Down 1.9 %

The stock has a 50 day simple moving average of GBX 26.11 and a 200 day simple moving average of GBX 27.73. The company has a current ratio of 4.59, a quick ratio of 1.77 and a debt-to-equity ratio of 1.78. The firm has a market capitalization of £118.42 million, a PE ratio of 2,610.00 and a beta of 0.57.

EKF Diagnostics Company Profile

EKF Diagnostics Holdings plc designs, develops, manufactures, and sells diagnostic instruments, reagents, and other ancillary products in Europe, the Middle East, the Americas, Asia, Africa, and internationally. It offers DiaSpect Tm hand-held hemoglobin analyzer; DiaSpect Hemoglobin T analyzer; Hemo Control, a hemoglobin analyzer that provides quantitative and lab quality hemoglobin results; and HemataStat II, a microhematocrit centrifuge that provides a quantitative hematocrit reading for six blood samples.